DK2132221T3 - Template-fikserede peptidomimetika - Google Patents

Template-fikserede peptidomimetika

Info

Publication number
DK2132221T3
DK2132221T3 DK07701901.6T DK07701901T DK2132221T3 DK 2132221 T3 DK2132221 T3 DK 2132221T3 DK 07701901 T DK07701901 T DK 07701901T DK 2132221 T3 DK2132221 T3 DK 2132221T3
Authority
DK
Denmark
Prior art keywords
tyr
template
dpro
cys
ala
Prior art date
Application number
DK07701901.6T
Other languages
English (en)
Inventor
Kerstin Moehle
John Anthony Robinson
Heiko Henze
Daniel Obrecht
Christian Ludin
Jan Wim Vrijbloed
Steven J Demarco
Reshmi Mukherjee
Barbara Romagnoli
Frank Gombert
Original Assignee
Polyphor Ltd
Univ Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polyphor Ltd, Univ Zuerich filed Critical Polyphor Ltd
Application granted granted Critical
Publication of DK2132221T3 publication Critical patent/DK2132221T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Non-Reversible Transmitting Devices (AREA)
DK07701901.6T 2007-02-28 2007-02-28 Template-fikserede peptidomimetika DK2132221T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CH2007/000101 WO2008104090A1 (en) 2007-02-28 2007-02-28 Template-fixed peptidomimetics

Publications (1)

Publication Number Publication Date
DK2132221T3 true DK2132221T3 (da) 2010-11-22

Family

ID=37891752

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07701901.6T DK2132221T3 (da) 2007-02-28 2007-02-28 Template-fikserede peptidomimetika

Country Status (21)

Country Link
US (7) US8399611B2 (da)
EP (1) EP2132221B1 (da)
JP (1) JP5140686B2 (da)
KR (1) KR101479148B1 (da)
CN (1) CN101641372B (da)
AT (1) ATE475667T1 (da)
AU (1) AU2007348171B2 (da)
BR (1) BRPI0721259C1 (da)
CA (1) CA2679414C (da)
DE (1) DE602007008150D1 (da)
DK (1) DK2132221T3 (da)
EA (1) EA017583B1 (da)
ES (1) ES2349879T3 (da)
HK (1) HK1138011A1 (da)
IL (1) IL200312A (da)
MX (1) MX2009008843A (da)
NO (1) NO342598B1 (da)
NZ (1) NZ579875A (da)
PL (1) PL2132221T3 (da)
PT (1) PT2132221E (da)
WO (1) WO2008104090A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007079597A1 (en) 2006-01-16 2007-07-19 Polyphor Ltd. Template - fixed peptidomimetics with antimicrobial activity
WO2008092281A1 (en) 2007-01-29 2008-08-07 Polyphor Ltd. Template-fixed peptidomimetics
ES2349879T3 (es) 2007-02-28 2011-01-12 Polyphor Ltd. Peptidomiméticos fijados sobre patrón.
EP2427476B1 (en) 2009-05-07 2018-08-08 Polyphor Ag Beta-hairpin peptidomimetics having cxcr4 antagonizing activity
WO2011066869A1 (en) * 2009-12-04 2011-06-09 Polyphor Ag Beta-hairpin peptidomimetics
RU2638802C2 (ru) 2011-05-16 2017-12-15 Джензим Корпорейшн Применение антагонистов cxcr4
WO2012168336A1 (en) * 2011-06-07 2012-12-13 Polyphor Ag Beta - hairpin peptidomimetics as cxc4 antagonists
ES2576959T3 (es) * 2011-10-07 2016-07-12 Polyphor Ag Peptidomiméticos fijados sobre plantilla como inhibidores del FPR1
JP6047231B2 (ja) * 2012-06-06 2016-12-21 ポリフォー・アクチェンゲゼルシャフトＰｏｌｙｐｈｏｒ Ａｇ β−ヘアピンペプチド模倣薬
CN104684925B (zh) * 2012-08-08 2021-11-30 波利弗尔股份公司 含有主链环化肽的组合
CN113194978B (zh) * 2018-10-05 2024-03-08 斯特姆里姆有限公司 具有间充质干细胞的动员活性的肽
MX2023005829A (es) 2020-11-19 2023-08-21 Spexis Ag Combinaciones farmaceuticas para tratar el cancer.
WO2022184320A2 (en) 2021-03-03 2022-09-09 Spexis Ag Medical use of cyclic peptides
WO2023285681A1 (en) 2021-07-16 2023-01-19 Spexis Ag Pharmaceutical combinations for treating cancer
WO2023285677A1 (en) 2021-07-16 2023-01-19 Spexis Ag Pharmaceutical combinations for treating cancer

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878804B1 (en) 1999-08-30 2005-04-12 University Of Zurich Synthesis of template-fixed β-hairpin loop mimetics
JP4310106B2 (ja) 2001-02-23 2009-08-05 ポリファー リミテッド 抗菌活性を有するテンプレート結合ペプチド擬似体
CN101157924A (zh) 2001-12-11 2008-04-09 人体基因组科学有限公司 嗜中性白细胞因子α
EP1483254A4 (en) * 2002-01-07 2005-06-08 Sequoia Pharmaceuticals INHIBITORS OF ANTI-RESISTANCE RETROVIRAL PROTEASE
BRPI0215855B1 (pt) 2002-08-20 2016-12-13 Polyphor Ltd peptídeos cíclicos ligados à matriz com ação antimicrobiana
US7855179B2 (en) 2002-10-02 2010-12-21 Polyphor Ltd. Template-fixed peptidomimetics with antimicrobial activity
AU2003232253A1 (en) 2003-05-02 2004-11-23 Polyphor Ag Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
ATE395355T1 (de) 2003-05-02 2008-05-15 Polyphor Ag Matrizenfixierte peptidmimetika als medikamente gegen hiv und krebs
US7681235B2 (en) 2003-05-19 2010-03-16 Radware Ltd. Dynamic network protection
DK1689863T3 (da) 2003-11-15 2014-08-25 Polyphor Ltd Template-fikserede beta-hairpinloopmimetika og deres anvendelse i fag-display
BRPI0520016B1 (pt) 2005-02-17 2021-11-16 Polyphor Ltd. Composto, composiqao farmaceutica, uso de composto e processo para a fabricaqao de composto
US9073973B2 (en) 2005-05-02 2015-07-07 Polyphor Ltd. Dye conjugates of template-fixed peptidomimetics
WO2007079597A1 (en) 2006-01-16 2007-07-19 Polyphor Ltd. Template - fixed peptidomimetics with antimicrobial activity
WO2008092281A1 (en) 2007-01-29 2008-08-07 Polyphor Ltd. Template-fixed peptidomimetics
ES2349879T3 (es) 2007-02-28 2011-01-12 Polyphor Ltd. Peptidomiméticos fijados sobre patrón.
CA2733117C (en) 2008-08-08 2016-03-22 Polyphor Ag Template-fixed peptidomimetics
WO2010060479A1 (en) 2008-11-26 2010-06-03 Polyphor Ag Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
EP2427476B1 (en) 2009-05-07 2018-08-08 Polyphor Ag Beta-hairpin peptidomimetics having cxcr4 antagonizing activity
DK2462147T3 (da) 2009-08-05 2015-02-23 Polyphor Ag Konformationelt begrænsede fuldsyntetiske makrocykliske forbindelser
WO2011060832A1 (en) 2009-11-20 2011-05-26 Polyphor Ag Template-fixed peptidomimetics with ccr10 antagonistic activity
WO2011066869A1 (en) 2009-12-04 2011-06-09 Polyphor Ag Beta-hairpin peptidomimetics
EP2531204B1 (en) 2010-02-05 2016-02-03 Polyphor AG Template - fixed peptidomimetics with cxcr7 modulating activity
WO2011095218A1 (en) 2010-02-05 2011-08-11 Polyphor Ag Template-fixed pep tidomime tics with cxcr7 modulating activity
US8895499B2 (en) 2010-08-05 2014-11-25 Polyphor Ag β-hairpin peptidomimetics
WO2012168336A1 (en) 2011-06-07 2012-12-13 Polyphor Ag Beta - hairpin peptidomimetics as cxc4 antagonists
ES2576959T3 (es) 2011-10-07 2016-07-12 Polyphor Ag Peptidomiméticos fijados sobre plantilla como inhibidores del FPR1
EP2836485B1 (en) 2012-03-17 2018-01-10 Polyphor Ag Conformationally constrained, fully synthetic macrocyclic compounds
JP6047231B2 (ja) 2012-06-06 2016-12-21 ポリフォー・アクチェンゲゼルシャフトＰｏｌｙｐｈｏｒ Ａｇ β−ヘアピンペプチド模倣薬
RS56350B1 (sr) 2012-08-08 2017-12-29 Polyphor Ag Kombinacije sa peptidom sa ciklizovanim osnovnim lancem
CN104684925B (zh) 2012-08-08 2021-11-30 波利弗尔股份公司 含有主链环化肽的组合
MX366088B (es) 2013-03-30 2019-06-27 Polyphor Ag Peptidomimeticos beta-horquilla.
MX366089B (es) 2013-03-30 2019-06-27 Polyphor Ag Peptidomimeticos beta-horquilla.
ES2925747T3 (es) 2013-12-27 2022-10-19 Spexis Ag Peptidomiméticos de horquilla beta como inhibidores selectivos de elastasa
ES2957258T3 (es) 2013-12-27 2024-01-16 Spexis Ag Peptidomiméticos de horquilla beta como inhibidores selectivos de elastasa

Also Published As

Publication number Publication date
CA2679414A1 (en) 2008-09-04
EP2132221B1 (en) 2010-07-28
CA2679414C (en) 2014-10-28
US10144765B2 (en) 2018-12-04
US8921325B2 (en) 2014-12-30
US20180127467A1 (en) 2018-05-10
ATE475667T1 (de) 2010-08-15
KR101479148B1 (ko) 2015-01-05
US10787486B2 (en) 2020-09-29
AU2007348171B2 (en) 2012-09-06
US20190100558A1 (en) 2019-04-04
CN101641372B (zh) 2012-11-28
NO342598B1 (no) 2018-06-18
DE602007008150D1 (de) 2010-09-09
EP2132221A1 (en) 2009-12-16
US20150080317A1 (en) 2015-03-19
US20170096453A1 (en) 2017-04-06
US20100048463A1 (en) 2010-02-25
EA200901178A1 (ru) 2010-04-30
BRPI0721259A2 (pt) 2013-01-15
JP2010519331A (ja) 2010-06-03
BRPI0721259C1 (pt) 2021-05-25
IL200312A (en) 2014-11-30
PT2132221E (pt) 2010-10-26
PL2132221T3 (pl) 2011-04-29
HK1138011A1 (en) 2010-08-13
EA017583B1 (ru) 2013-01-30
US9879047B2 (en) 2018-01-30
CN101641372A (zh) 2010-02-03
US8399611B2 (en) 2013-03-19
MX2009008843A (es) 2009-08-28
KR20100014596A (ko) 2010-02-10
NO20093064L (no) 2009-09-28
IL200312A0 (en) 2010-04-29
NZ579875A (en) 2012-02-24
JP5140686B2 (ja) 2013-02-06
ES2349879T3 (es) 2011-01-12
WO2008104090A1 (en) 2008-09-04
BRPI0721259B8 (pt) 2020-09-15
US11421001B2 (en) 2022-08-23
AU2007348171A1 (en) 2008-09-04
US20200399317A1 (en) 2020-12-24
US9556234B2 (en) 2017-01-31
US20130150299A1 (en) 2013-06-13
BRPI0721259B1 (pt) 2020-04-07

Similar Documents

Publication Publication Date Title
ATE475667T1 (de) Templat-fixierte peptidomimetika
PE20140382A1 (es) Polipeptidos derivados de la il-2 con actividad agonista para la terapia del cancer e infecciones cronicas
CL2012000163A1 (es) Compuestos derivados de quinazolina o pirido[2,3-d]pirimidina, inhibidores de la autofagia; composicion farmaceutica; y su uso para el tratamiento del cancer, pancreatitis, neurodegeneracion, entre otras.
MX2011008869A (es) Derivados de indol como antagonistas del receptor de la molecula homologa a receptor de quimioatrayente expresada en celulas th2.
MX2009003129A (es) Derivados de oxadiazol con propiedades anti-inflamatorias e inmunosupresoras.
CL2012002250A1 (es) Compuestos heterociclicos fusionados derivados de pirimidinonas, inhibidores potentes de cdc7; composicion farmaceutica; y su uso en la prevencion o el tratamiento del cancer.
CL2012000623A1 (es) Compuestos derivados de 4-[4,4-dimetil-5oxo-3-(piridin-ilmetil)-2-tioxoimidazolidin-1-il]-2-(trifluorometil)benzonitrilo, con propiedades antiandrogenicas; metodo de preparacion; composcion farmaceutica; y su uso para el tratamiento y/o profilaxis de cancer de prostata.
ME01009B (me) Kristalni oblici dimetoksi docetaksela i postupak za njihovo dobijanje
UA109878C2 (uk) Похідні ізохінолінону, фармацевтична композиція на їх основі (варіанти) та спосіб лікування захворювань (варіанти)
WO2010009892A3 (en) Compositions for the treatment of pain and/or inflamation
CL2011002300A1 (es) Compuestos derivados de 2,4-diamiropirimidinas 5-sustitudas inhibidoras de quinasa ptk2; preparaciones farmaceuticas; y su uso para el tratamiento y/o la prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunes.
UA98658C2 (uk) Циклічні депсипептиди
PH12019550241A1 (en) Mic-1 compounds and uses thereof
ECSP099675A (es) Compuestos heterocíclicos, composición y métodos de uso
CL2012002887A1 (es) Combinación farmacéutica que comprende compuestos derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituida, compuestos derivados de n-(2-arilamino)arilsulfonamida y opcionalmente otros agentes farmacéuticos adicionales; kit faramacéutico; método de tratamiento; y su uso para el tratamiento o la profilaxis del cáncer.
AU2013208104A8 (en) Benzhydrol-pyrazole derivatives having kinase inhibitory activity and uses thereof
CR20210021A (es) Apirasas solubilizadas, métodos y usos
BR112014014572A2 (pt) composição bioativa
EP3887377A4 (en) 7-, 8- AND 10- SUBSTITUTED AMINOTRIAZOLOCHINAZOLINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE
CL2008001322A1 (es) Compuestos derivados de triazolil-aminopirimidina, sustituida con heterociclos; composicion farmaceutica; y uso en el tratamiento del cancer.
TW200738232A (en) Use of vanilloid receptor-1 antagonists for the prevention and treatment of glaucoma
WO2008120263A3 (en) Prokineticins receptors antagonists, derivatives and uses thereof
BRPI0510407A (pt) derivados de 3-amino-2-fenilpirrolidina
GB0515025D0 (en) Organic compounds
AU2013208087A8 (en) Tryptoline derivatives having kinase inhibitory activity and uses thereof